press release

icons.png Research & Development Manufacturing Regulatory Outlicence & Supply

Generic Partners trialling “proof of concept” installation of LORENZ docuBridge®

Frankfurt, 21 October 2014

 

Generic Partners Pty Ltd, headquartered in Melbourne, Australia, is currently conducting a “proof of concept” evaluation of the LORENZ docuBridge® software solution to see if it will fulfil their local eCTD submission requirements both in Australia and in other regions where the generic pharmaceutical company does business.

In particular, docuBridge® is being evaluated for its document management functionality, which could be used throughout the entire Generic Partners organization. During this evaluation period, team members will be trained on the product, and will receive the same customer support as if they had already purchased it.

“We’re very pleased to see Generic Partners taking advantage of this “proof of concept” evaluation option. This provides them an opportunity to understand not just the product itself, but also the level support we can provide them. Together this will give them a deeper insight into the full potential of the software,” says Wolfgang Witzel, President, LORENZ Life Sciences Group. “With the Australian TGA now moving towards accepting eCTD submissions, Generic Partners clearly want to be at the front of the pack, not only in terms of eCTDs, but also for other future developments in electronic submissions.”

LORENZ docuBridge® is the most established standard solution for small, medium and large companies as well as regulatory agencies to compile, publish, manage and review electronic submissions. The software complies with all global eCTD standards, NeeS, VNeeS, and AMNOG. The product was recently selected by the Australian TGA as its eCTD review solution.

“As Generic Partners expands its operations to other countries outside of Australia, we want to be prepared to market our products as soon as possible. This means we have to be well-organized from a regulatory perspective, and in providing other supporting documentation,” notes Aman Madan, COO and Country Head, Australia of Generic Partners. “Naturally being prepared for what’s happening in Australia is also important. This “proof of concept” evaluation will definitely give us a much better overview of our own current working processes, and how we integrate a product like LORENZ docuBridge® into them.”

About Generic Partners Pty Ltd

Generic Partners is a global producer of non-infringing generic pharmaceuticals. Surpassing a 100-strong portfolio in five short years since inception, we relish getting clients First to Market again and again. If you wish to overcome R&D challenges, sharpen patent strategies, improve formulation quality, reduce manufacturing costs, accelerate regulatory approval, profit from out-licensing, and receive dependable supply, please visit our http://generic.partners website.

About LORENZ Life Sciences Group

LORENZ Life Sciences Group (www.lorenz.cc) has been developing and marketing software solutions for the Life Sciences market since 1989. LORENZ's solutions are geared specifically for submission assembly, review, publishing, validation and management. LORENZ docuBridge® is the most widely used eCTD submission management system for U.S., European and Japanese formats among many others, and is popular with regulatory agencies and industry alike. With over 300 installations in over 25 countries, LORENZ has a strong worldwide customer base.